Atrial Fibrillation New Onset
Conditions
Keywords
Atrial fibrillation, breast cancer, lung cancer, thoracic malignancies, cardiotoxicity
Brief summary
Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer. Each patient will have 12 lead ECG prior, and daily during radiotherapy.
Detailed description
Collected data will be truly anonymised and individuals will no longer identifiable, and than evaluated for occurrence of atrial fibrillation. Inclusing Criteria: 1. Patients with radiotherapy for thoracic malignancy or breast cancer 2. Between 18-99 years-old Exclusion Criteria: 1. Patients with history of radiotherapy 2. Patients with history of atrial fibrillation 3. Patients with pacemaker implantation
Interventions
DIAGNOSTIC_TESTECG
12 lead ecg for each participant
Sponsors
Istanbul University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No
Inclusion criteria
* Patients with radiotherapy for thoracic malignancy or breast cancer * Between 18-99 years-old
Exclusion criteria
* Patients with history of radiotherapy * Patients with history of atrial fibrillation * Patients with pacemaker implantation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Occurrence of atrial fibrillation | 1 day During radiotherapy | Occurrence of atrial fibrillation |
| Onset time of atrial fibrillation | 1 day During radiotherapy | Onset time of atrial fibrillation |
Countries
Turkey (Türkiye)
Outcome results
None listed